个人简介
教育经历
2007.09-2013.06电子科技大学生命科学与技术学院生物医学工程（肿瘤基因组方向），博士
2002.09-2006.06中南大学信息科学与技术学院计算机科学与技术，本科
工作经历
2019.01-至今南京中医药大学医学与生命学院公共卫生学系教授
2013.12-2018.12约翰霍普金斯大学医学院博士后研究员
社会和学术团体服务
1.美国甲状腺协会会员
2.中国抗癌协会肿瘤标志专业委员会肿瘤测序及大数据分析协作组委员
3.JamaOncology,Bioinformatics,BriefingsinBioinformatics,InternationalJournalofCancer,Thyroid,InternationalJournalofBiologicalSciences等10多个杂志的审稿人
人才项目
江苏省特聘教授（2018）
近期论文
查看导师新发文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
近年论文列表
1.ShenX#,ZhuG#,LiuR#,ViolaD,EliseiR,PuxedduE,FugazzolaL,ColomboC,JarzabB,CzarnieckaA,LamAK,MianC,VianelloF,YipL,Riesco-EizaguirreG,SantistebanP,O'NeillCJ,SywakMS,Clifton-BlighR,BendlovaB,SýkorováV,XingM.PatientAge-AssociatedMortalityRiskIsDifferentiatedbyBRAFV600EStatusinPapillaryThyroidCancer.JClinOncol.2018,36(5):438-445.
2.WangF#,ZhaoS#,ShenX,ZhuG,LiuR,ViolaD,EliseiR,PuxedduE,FugazzolaL,ColomboC,JarzabB,CzarnieckaA,LamAK,MianC,VianelloF,YipL,Riesco-EizaguirreG,SantistebanP,O'NeillCJ,SywakMS,Clifton-BlighR,BendlovaB,SýkorováV,WangY,XingM.BRAFV600EConfersMaleSexDisease-SpecificMortalityRiskinPatientsWithPapillaryThyroidCancer.JClinOncol.2018,36(27):2787-2795.
3.HuangY#,QuS#,ZhuG,WangF,LiuR,ShenX,ViolaD,EliseiR,PuxedduE,FugazzolaL,ColomboC,JarzabB,CzarnieckaA,LamAK,MianC,VianelloF,YipL,Riesco-EizaguirreG,SantistebanP,O'NeillCJ,SywakMS,Clifton-BlighR,BendlovaB,SýkorovaV,XingM.BRAFV600EMutation-AssistedRiskStratificationofSolitaryIntrathyroidalPapillaryThyroidCancerforPrecisionTreatment.JNatlCancerInst.2018,110(4):362-370.
4.ShenX#,LiuR,XingM.Asix-genotypegeneticprognosticmodelforpapillarythyroidcancer.EndocrRelatCancer.2017,24(1):41-52.
5.ZhangT#,ShenX#,LiuR,ZhuG,BishopJ,XingM.EpigeneticallyupregulatedWIPF1playsamajorroleinBRAFV600E-promotedpapillarythyroidcanceraggressiveness.Oncotarget.2017,8(1):900-914.
6.WangF#,YuX#,ShenX#,ZhuG,HuangY,LiuR,ViolaD,EliseiR,PuxedduE,FugazzolaL,ColomboC,JarzabB,CzarnieckaA,LamAK,MianC,VianelloF,YipL,Riesco-EizaguirreG,SantistebanP,O'NeillCJ,SywakMS,Clifton-BlighR,BendlovaB,SýkorováV,WangY,LiuS,ZhaoJ,ZhaoS,XingM.ThePrognosticValueofTumorMultifocalityinClinicalOutcomesofPapillaryThyroidCancer.JClinEndocrinolMetab.2017,102(9):3241-3250.
7.LiuD,ShenX,ZhuG,XingM.REC8isanoveltumorsuppressorgeneepigeneticallyrobustlytargetedbythePI3Kpathwayinthyroidcancer.Oncotarget.2015,6(36):39211-24
8.ZhangL,HaoC,ShenX,HongG,LiH,ZouX,LiuC,GuoZ.Rank-basedpredictorsforresponseandprognosisofneoadjuvanttaxane-anthracycline-basedchemotherapyinbreastcancer.BreastCancerResTreat.2013,139(2):361-369
9.ShenX,LiS,ZhangL,LiH,HongG,ZhouX,ZhengT,ZhangW,HaoC,ShiT,LiuC,GuoZ.Anintegratedapproachtouncoverdrivergenesinbreastcancermethylationgenomes.PLoSOne.2013，8(4):e61214.
10.ZhuJ,XiaoH,ShenX,WangJ,ZouJ,etal.,GuoZ.Viewingcancergenesfromco-evolvinggenemodules.Bioinformatics.2010,26(7):919-24
国际会议论文摘要
1.ShenX,ZhuG,LiuR,XingM,TheinternationalPTCstudygroup.PatientAge-AssociatedMortalityRiskIsDifferentiatedbyBRAFV600EStatusinPapillaryThyroidCancer,87thAnnualMeetingoftheAmericanThyroidAssociationVictoria,BritishColumbia,2017.10.18-2017.10.22大会报告
2.ShenX,XingM.CoexistingTERTpromoterandBRAFV600EorRASmutationsdefinethemostaggressivepapillarythyroidcancer-aconfirmationintheTCGAdata,86thannualmeetingoftheAmericanThyroidAssociation.Denver,2016.9.21-2016.9.25大会报告
3.ShenX,LiS,GuoZ.Identifyingdrivergenesofbreastcancerbyintegratedanalysisofmethylationandexpressiondatainpaireddisease-normalsamplesofpatients,5thInternationalConferenceon,BioinformaticsandBiomedicalTechnology.Macau,2013.3.17-2013.3.18大会报告
京公网安备 11010802027423号